RAFAEL HOLDINGS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
RAFAEL HOLDINGS, INC. (RFL) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $80.80 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-06-11
- 2026-04-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $80.80M.
- 2026-01-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $83.26M.
- 2025-10-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $89.18M.
- 2025-07-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $98.37M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-04-30 | $80.80M 10-Q · filed 2026-06-11 | |
| 2026-01-31 | $83.26M 10-Q · filed 2026-06-11 | |
| 2025-10-31 | $89.18M 10-Q · filed 2026-03-16 | |
| 2025-07-31 | $98.37M 10-Q · filed 2026-06-11 | |
| 2025-04-30 | $84.52M 10-Q · filed 2026-06-11 | |
| 2025-01-31 | $72.56M 10-Q · filed 2026-06-11 | |
| 2024-10-31 | $77.38M 10-Q · filed 2026-03-16 | |
| 2024-07-31 | $86.26M 10-Q · filed 2026-06-11 | |
| 2024-04-30 | $90.56M 10-Q · filed 2025-06-11 | |
| 2024-01-31 | $102.25M 10-Q · filed 2025-06-11 | |
| 2023-10-31 | $94.51M 10-Q · filed 2025-03-14 | |
| 2023-07-31 | $96.63M 10-K · filed 2025-10-29 | |
| 2023-04-30 | $94.89M 10-Q · filed 2024-06-14 | |
| 2023-01-31 | $96.53M 10-Q · filed 2024-06-14 | |
| 2022-10-31 | $99.97M 10-Q · filed 2024-03-14 | |
| 2022-07-31 | $97.21M 10-K/A · filed 2024-12-20 | |
| 2022-04-30 | $94.91M 10-Q · filed 2023-06-13 | |
| 2022-01-31 | $99.66M 10-Q · filed 2023-06-13 | |
| 2021-10-31 | $113.06M 10-Q · filed 2023-03-14 | |
| 2021-07-31 | $136.70M 10-K · filed 2023-10-30 | |
| 2021-04-30 | $141.26M 10-Q · filed 2022-06-14 | |
| 2021-01-31 | $135.39M 10-Q · filed 2022-06-14 | |
| 2020-10-31 | $129.32M 10-Q · filed 2022-03-17 | |
| 2020-07-31 | $130.53M 10-K · filed 2022-10-31 | |
| 2020-04-30 | $135.83M 10-Q · filed 2021-06-14 | |
| 2020-01-31 | $137.92M 10-Q · filed 2021-06-14 | |
| 2019-10-31 | $138.96M 10-Q · filed 2021-03-17 | |
| 2019-07-31 | $124.76M 10-K · filed 2021-10-18 | |
| 2019-04-30 | $127.42M 10-Q · filed 2020-06-09 | $126.86M 10-Q · filed 2019-06-05 |
| 2019-01-31 | $128.39M 10-Q · filed 2020-06-09 | $127.83M 10-Q · filed 2019-03-12 |
| 2018-10-31 | $115.69M 10-Q · filed 2020-03-05 | $115.13M 10-Q · filed 2018-12-10 |
| 2018-07-31 | $116.12M 10-K · filed 2020-10-29 | $115.56M 10-K · filed 2018-10-15 |
| 2018-04-30 | $114.95M 10-Q · filed 2019-06-05 | |
| 2018-01-31 | $52.63M 10-Q · filed 2019-06-05 | |
| 2017-07-31 | $62.08M 10-K · filed 2019-10-04 | |
| 2016-07-31 | $48.81M 10-K · filed 2018-10-15 | |
| 2015-07-31 | $48.11M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |